171 related articles for article (PubMed ID: 14531336)
1. [Influence of valproic acid (depakine I.V.) on human placenta metabolism--experimental model].
Semczuk-Sikora A; Rogowska W; Semczuk M
Ginekol Pol; 2003 Aug; 74(8):596-602. PubMed ID: 14531336
[TBL] [Abstract][Full Text] [Related]
2. [Effect of anti-epileptic drugs on human placenta and the fetus].
Semczuk-Sikora A; Semczuk M
Ginekol Pol; 2004 Feb; 75(2):166-9. PubMed ID: 15108592
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid transfer across human placental cotyledon during dual perfusion in vitro.
Semczuk-Sikora A; Czuczwar S; Semczuk A; Kwasniewska A; Semczuk M
Ann Agric Environ Med; 2010; 17(1):153-7. PubMed ID: 20684493
[TBL] [Abstract][Full Text] [Related]
4. Placental transfer of valproic acid after liposome encapsulation during in vitro human placenta perfusion.
Barzago MM; Bortolotti A; Stellari FF; Diomede L; Algeri M; Efrati S; Salmona M; Bonati M
J Pharmacol Exp Ther; 1996 Apr; 277(1):79-86. PubMed ID: 8613970
[TBL] [Abstract][Full Text] [Related]
5. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy.
Vajda FJ; O'brien TJ; Hitchcock A; Graham J; Cook M; Lander C; Eadie MJ
J Clin Neurosci; 2004 Nov; 11(8):854-8. PubMed ID: 15519862
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy A
Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
[TBL] [Abstract][Full Text] [Related]
7. Adverse placental effects of valproic acid: Studies in perfused human placentas.
Rubinchik-Stern M; Shmuel M; Bar J; Kovo M; Eyal S
Epilepsia; 2018 May; 59(5):993-1003. PubMed ID: 29667177
[TBL] [Abstract][Full Text] [Related]
8. Three cases of delivery under sodium valproate--placental transfer, milk transfer and probable teratogenicity of sodium valproate.
Tsuru N; Maeda T; Tsuruoka M
Jpn J Psychiatry Neurol; 1988 Mar; 42(1):89-96. PubMed ID: 3135429
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Neurology; 2015 Sep; 85(10):866-72. PubMed ID: 26085607
[TBL] [Abstract][Full Text] [Related]
10. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid.
Jäger-Roman E; Deichl A; Jakob S; Hartmann AM; Koch S; Rating D; Steldinger R; Nau H; Helge H
J Pediatr; 1986 Jun; 108(6):997-1004. PubMed ID: 3086531
[TBL] [Abstract][Full Text] [Related]
11. Placental passage of antiepileptic drugs at delivery and neonatal outcomes.
Bank AM; Stowe ZN; Newport DJ; Ritchie JC; Pennell PB
Epilepsia; 2017 May; 58(5):e82-e86. PubMed ID: 28387929
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy, delivery, and outcome for the child in maternal epilepsy.
Veiby G; Daltveit AK; Engelsen BA; Gilhus NE
Epilepsia; 2009 Sep; 50(9):2130-9. PubMed ID: 19490036
[TBL] [Abstract][Full Text] [Related]
13. [Effects of antiepileptic drugs on delivery and early childhood--comparison among mono-therapies of valproic acid, phenytoin, carbamazepine and phenobarbital].
Tanaka H; Takeda A; Izumi M; Okada H; Ishikawa S
Rinsho Shinkeigaku; 1991 Mar; 31(3):266-9. PubMed ID: 1893664
[TBL] [Abstract][Full Text] [Related]
14. Characterizing the effects of in utero valproic acid exposure on murine fetoplacental development.
Shafique S; Winn LM
Placenta; 2021 Sep; 112():141-152. PubMed ID: 34352490
[TBL] [Abstract][Full Text] [Related]
15. Lack of teratogenicity of trans-2-ene-valproic acid compared to valproic acid in rats.
Vorhees CV; Acuff-Smith KD; Weisenburger WP; Minck DR; Berry JS; Setchell KD; Nau H
Teratology; 1991 Jun; 43(6):583-90. PubMed ID: 1882349
[TBL] [Abstract][Full Text] [Related]
16. [Transfer Mechanisms of Compounds between Mother and Fetus/Infant Aimed for Optimized Medication during Pregnancy and Breastfeeding].
Furugen A
Yakugaku Zasshi; 2020; 140(10):1199-1206. PubMed ID: 32999198
[TBL] [Abstract][Full Text] [Related]
17. Teratogenicity of sodium valproate.
Alsdorf R; Wyszynski DF
Expert Opin Drug Saf; 2005 Mar; 4(2):345-53. PubMed ID: 15794725
[TBL] [Abstract][Full Text] [Related]
18. [Fetal valproate syndrome].
Taubøll E; Gjerstad L; Henriksen T; Husby H
Tidsskr Nor Laegeforen; 2003 Oct; 123(19):2765. PubMed ID: 14600761
[No Abstract] [Full Text] [Related]
19. Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothers.
Nau H; Rating D; Koch S; Häuser I; Helge H
J Pharmacol Exp Ther; 1981 Dec; 219(3):768-77. PubMed ID: 6795343
[TBL] [Abstract][Full Text] [Related]
20. Antiepileptic medication during pregnancy: does fetal genotype affect outcome?
Atkinson DE; Brice-Bennett S; D'Souza SW
Pediatr Res; 2007 Aug; 62(2):120-7. PubMed ID: 17597651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
